nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.04.2010 | Consensus Report

Austrian consensus recommendations for the treatment of patients with multiple myeloma

verfasst von: E. Gunsilius, Johannes Drach, MD, for the myeloma platform of the Austrian Society of Hematology & Oncology (ÖGHO), for the myeloma platform of the Austrian Society of Hematology & Oncology (ÖGHO)

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Vorheriger Artikel Stemming cancer by Hedgehog pathway inhibition: from flies to bedside

Nächster Artikel Iron chelation therapy in myelodysplastic syndromes: evidence-based rationale and comparison of guidelines

Titel: Austrian consensus recommendations for the treatment of patients with multiple myeloma
verfasst von: E. Gunsilius
Johannes Drach, MD
for the myeloma platform of the Austrian Society of Hematology & Oncology (ÖGHO)
for the myeloma platform of the Austrian Society of Hematology & Oncology (ÖGHO)
Publikationsdatum: 01.04.2010
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 1/2010
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-010-0175-x

CECOG’s services at a glance

CECOG News

Haemolytic anaemia triggered by antitumoural “biological agents” and immunotherapies with monoclonal antibodies: short review of the literature

Special Report

Stemming cancer by Hedgehog pathway inhibition: from flies to bedside

Short Review

Allogeneic stem cell transplantation (SCT) in Ph+ CML: still a therapeutic option?

Short Review

Fibroblast growth factor receptors (FGFR) as possible therapeutic targets in human non-small cell lung cancer

Short Review

Changing paradigms in clinical trials

Editorial

Springer Medizin Österreich

Austrian consensus recommendations for the treatment of patients with multiple myeloma

Weitere Artikel der Ausgabe 1/2010

CECOG’s services at a glance

Haemolytic anaemia triggered by antitumoural “biological agents” and immunotherapies with monoclonal antibodies: short review of the literature

Stemming cancer by Hedgehog pathway inhibition: from flies to bedside

Allogeneic stem cell transplantation (SCT) in Ph+ CML: still a therapeutic option?

Fibroblast growth factor receptors (FGFR) as possible therapeutic targets in human non-small cell lung cancer

Changing paradigms in clinical trials

Springer Medizin Österreich

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

CECOG’s services at a glance

Haemolytic anaemia triggered by antitumoural “biological agents” and immunotherapies with monoclonal antibodies: short review of the literature

Stemming cancer by Hedgehog pathway inhibition: from flies to bedside

Allogeneic stem cell transplantation (SCT) in Ph+ CML: still a therapeutic option?

Fibroblast growth factor receptors (FGFR) as possible therapeutic targets in human non-small cell lung cancer

Changing paradigms in clinical trials